This inventor holds 11 USPTO granted patents and 1 EPO patent. Top assignees: Harvard College, Massachusetts Institute of Technology, The Broad Institute, Inc.. Active years: 1999-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, MD (US) (2002)
- San Diego, CA (US) (2002 - 2008)
- Framingham, MA (US) (2008)
- Cambridge, MA (US) (1999 - 2024)
Company Filing History:
3 out of 3,071 
3 out of 8,578 
3 out of 483 
Years Active: 1999-2026
Title: The Innovative Journey of Marshall Morningstar
Introduction
Marshall Morningstar, located in San Diego, CA, is a distinguished inventor recognized for his significant contributions to the field of medical research and pharmaceutical innovations. With a remarkable portfolio of ten patents, he has dedicated his career to developing compounds aimed at combating various parasitic diseases.
Latest Patents
Among his latest patents is a groundbreaking innovation titled "Compounds and methods for the treatment of parasitic diseases." This patent describes novel compounds that are useful in treating ailments caused by parasites, such as malaria and cryptosporidiosis. These compounds, along with their pharmaceutically acceptable salts, can be formulated into both pharmaceutical and veterinary compositions, highlighting their versatility and potential impact on global health.
Career Highlights
Marshall has had a remarkable career, having worked at prestigious institutions including the Massachusetts Institute of Technology and the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. His work in these esteemed organizations has positioned him as a leader in his field, making significant strides towards improving treatments for parasitic diseases.
Collaborations
Throughout his career, Marshall Morningstar has collaborated with esteemed colleagues such as John M. Essigmann and Robert G. Croy. These collaborations have facilitated the exchange of ideas and expertise, further advancing the research and development of his innovative compounds.
Conclusion
In conclusion, Marshall Morningstar's dedication to innovation and his impressive patent portfolio reflect his commitment to combating parasitic diseases. His work continues to inspire and pave the way for future advancements in the pharmaceutical field, ultimately contributing to the health and well-being of countless individuals affected by these diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile